Antidepressants Flashcards
Biogenic Amine Theory of Depression
Depression results from deficiency in one of the NT’s (norepinephrine (NE), dopamine, and serotonin (5HT)) in specific parts of the brain.
3 Reasons for deficiency of NT’s (Biogenic Amine Theory of Depression)
1) Monoamine oxidase (MAO) may break them down to be recycled or restored in the neuron
2) Rapid fire of neurons may lead to their depletion
3) The number or sensitivity of postsynaptic receptors have been down-regulated
3 Ways Antidepressant drugs work to counteract deficient NT’s
1) inhibit the effects of MAO, leading to increased NE or 5HT in the synaptic cleft.
2) block reuptake by the releasing nerve= increased NT levels in the synaptic cleft.
3) regulate receptor sites and the breakdown of NT’s =accumulation of NT in the synaptic cleft.
3 Antidepressant Drug Classifications
Tricyclic antidepressants (TCAs) MAO inhibitors (MAOIs) Selective serotonin reuptake inhibitors (SSRIs)
Tricyclic Antidepressants (TCA's) Actions *also Anti-cholinergic
Reduce the reuptake of 5HT and NE into nervesbes
TCA’s in general may best suited for Depression with symptoms of anxiety and sleep disturbance. *Enuresis in kids 6+. Chronic Pain.
Clomipramine Tx OCD.
Tricyclic Antidepressants (TCA's) Indications *No specific indications except with PEDS. The choice of which drug comes down to side effects vs. effectiveness.
Relief of symptoms of depression
Used for patients with sleep disorders
Treatment of enuresis
Chronic pain
Tricyclic Antidepressants (TCA’s) Pharmacokinetics
Absorbed from the GI tract
Peak in 2 to 4 hours
Bound to plasma proteins and lipid soluble
Metabolized in the liver and excreted in the urine
T½ 8 to 46 hours
Tricyclic Antidepressants (TCA’s) Contraindications and Cautions
Known allergy, recent MI, myelography, pregnancy, and lactation
Cautions: CV disease, angle closure glaucoma, urinary retention, and manic depression
SUICIDEALITY in Kids/Adolescent
Tricyclic Antidepressants (TCA’s) Adverse reactions
Sedation, sleep disturbances, fatigue, hallucinations, ataxia, dry mouth, constipation, nausea, and vomiting Anticholinergic side effects
Tricyclic Antidepressants (TCA’s) DD Interactions
MAOIs, cimetidine, fluoxetine, ranitidine, and oral anticoagulants. sympathomimetic drugs: clonidine=risk for HTN, and Arrhythmia
TCA’s for PEDS patients
Caution: Unpredictable Rx. Monitor for Suicidal Ideation. Clomipramine, Imipramine, Nortriptyline, and Trimipramine have established PEDS Dosage
TCA Antidepressant Name ending
“amine” “tyline” “apine” Be Careful…many other drugs have similar, even in the other classifications. Also Doxepin does not fit name ending.
Prototype Drug Imipramine Indications
Tx depression; enuresis in children older than 6 years, off-label consideration— control of chronic pain.
Prototype Drug Imipramine Actions
Inhibits presynaptic reuptake of norepinephrine and serotonin; anticholinergic at central nervous system and peripheral receptors; sedating.
Prototype Drug Imipramine Pharmacokinetics
Route: Oral O=Varies D=2–4 h
T1/2: 8 to 16 hours, metabolized in the liver, excretion in the urine.
Prototype Drug Imipramine Adverse Effects
Sedation, anticholinergic effects, confusion, anxiety, orthostatic hypotension, dry mouth, constipation, urinary retention, rash, bone marrow depression.
Monoamine Oxidase Inhibitors (MAOIs) Action
Irreversibly inhibit MAOs, allowing norepinephrine, serotonin, and dopamine to accumulate in the synaptic cleft
Monoamine Oxidase Inhibitors (MAOIs) Indication
Treatment of patients with depression who are unresponsive to or unable to take other safer antidepression agents